23
236200.KQ Suprema Inc
- Market cap
- KRW 313B
- P/E
- 7.2x
- P/B
- 1.06x
- ROE
- 19.5%
- Dividend yield
- 0.88%
- Fundamental score
- 3.0/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 236200.KQ undervalued?
Graham number236200.KQ trades 41.8% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Suprema Inc fundamental analysis
14 of 22 checks passedROE 1/2
Moderate return on equity (19.5%), between 10% and 20%.
ROA 1/1
Return on assets (17.8%) is above the industry median (3.1%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-1.3%) is not above the 5-year average (28.7% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-1.3%) is below the industry median (21.3%).
Revenue Growth 2/2
Revenue grew 15.4% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (0.0%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 198.6x against interest expense, well covered.
PE vs Market 1/1
PE (7.2x) is below the market median (11.3x).
PE vs Industry 1/1
PE (7.2x) is below the industry median (7.7x).
PBV 0/1
Price to book (1.1x) is above the industry median (0.6x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 7.6, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.25, growth is cheap.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Suprema Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Suprema Inc
Suprema Inc. develops and manufactures biometric and security products in South Korea and internationally. The company offers biometric access control systems, time and attendance solutions, fingerprint live scanners, mobile authentication solutions, and embedded fingerprint modules. It also provides access control, mobile access, and time and attendance solutions; BioSign, a mobile authentication solution; and integrated solutions, including BioStar 2, a Web-based security …
Full company profileSuprema Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Suprema Inc annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 42.2B | 47.1B | 52.8B | 72.1B | 57.8B | 72.6B | 89.4B | 94.6B | 108B | 137B | 143B |
| Gross Profit | 20.7B | 25.0B | 28.6B | 46.5B | 34.0B | 43.1B | 54.6B | 58.1B | 70.5B | 90.8B | 96.6B |
| Operating Income | 10.8B | 12.4B | 8.47B | 24.5B | 10.1B | 15.8B | 17.2B | 16.4B | 22.1B | 32.7B | 31.1B |
| EBITDA | - | - | - | - | - | - | 22.6B | 28.2B | 41.7B | 41.1B | 71.8B |
| Net Income | 11.1B | 9.09B | 11.4B | 25.9B | 9.42B | 22.7B | 17.9B | 23.0B | 32.5B | 32.4B | 57.7B |
| EPS | 1,571 | 1,284 | 1,608 | 3,626 | 1,317 | 3,216 | 2,572 | 3,314 | 4,709 | 4,647 | 8,286 |
| Balance Sheet | |||||||||||
| Total Assets | 94.7B | 103B | 116B | 149B | 154B | 176B | 194B | 218B | 260B | 300B | 324B |
| Total Liabilities | 6.44B | 6.07B | 7.27B | 12.2B | 7.97B | 9.68B | 12.0B | 14.3B | 23.5B | 28.8B | 28.1B |
| Shareholders' Equity | 88.2B | 97.2B | 109B | 136B | 146B | 166B | 182B | 204B | 237B | 271B | 296B |
| Cash & Short-term Investments | 44.4B | 48.7B | 62.4B | 63.5B | 57.6B | 52.9B | 79.2B | 85.3B | 68.2B | 51.3B | 77.4B |
| Total Debt | - | - | - | 21.9M | - | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 13.3B | 11.1B | 14.9B | 26.8B | 15.0B | 17.7B | 18.9B | 23.4B | 34.2B | 37.3B | 3.83B |
| Capital Expenditure | 3.29B | 519M | 487M | 613M | 4.17B | 2.29B | 1.68B | 4.07B | 5.41B | 10.1B | 6.38B |
| Free Cash Flow | - | - | - | 20.5B | 8.35B | 11.8B | 14.9B | 19.3B | 28.8B | 27.2B | -2.55B |
| Ratios | |||||||||||
| ROE | 12.6% | 9.4% | 10.5% | 19.0% | 6.5% | 13.6% | 9.8% | 11.2% | 13.7% | 11.9% | 19.5% |
| ROA | 11.7% | 8.8% | 9.8% | 17.5% | 6.1% | 12.9% | 9.2% | 10.5% | 12.5% | 10.8% | 17.8% |
| Net Profit Margin | 26.4% | 19.3% | 21.6% | 36.0% | 16.3% | 31.2% | 20.0% | 24.3% | 30.0% | 23.6% | 40.4% |
| Debt to Equity | - | - | - | 0.00x | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Suprema Inc dividends
- Dividend yield
- 0.88%
- Forward dividend
- 400.00 KRW
- Payout ratio
- -
- Ex-dividend date
- Jun 29, 2026
Who owns Suprema Inc
- Insiders 33.92%
- Institutions 2.99%
- Public & others 63.09%
- Shares outstanding 6.86M
- Free float 3.94M
Suprema Inc company profile
- Company name
- Suprema Inc
- Ticker
- 236200.KQ
- ISIN
- KR7236200002
- Exchange
- KOSDAQ
- Sector
- Industrials
- Industry
- Electronic Equipment, Instruments & Components
- Employees
- 235
- Fiscal year end
- December
- Address
- Parkview Tower, Seongnam-si, South Korea, 13554
- Phone
- 82 3 1783 4502
- Website
- supremainc.com
About Suprema Inc
Suprema Inc. develops and manufactures biometric and security products in South Korea and internationally. The company offers biometric access control systems, time and attendance solutions, fingerprint live scanners, mobile authentication solutions, and embedded fingerprint modules. It also provides access control, mobile access, and time and attendance solutions; BioSign, a mobile authentication solution; and integrated solutions, including BioStar 2, a Web-based security platform that enables to integrate with third-party systems. In addition, the company offers biometric readers, rf/ mobile readers, intelligent controller, open platform, peripherals, and OEM fingerprint modules. It serves construction, data center, healthcare, commercial, infrastructure, and manufacturing industries. Suprema Inc. was founded in 2000 and is headquartered in Seongnam-si, South Korea.
Suprema Inc management
7- Mr. Jae-Won LeeRepresentative Chairman & CEO · born 1968
- Mr. Han-Cheol KimRepresentative Vice Chairman, GM & Biostar Business Division Head · born 1970
- Mr. Song Bong-SeopPresident & Research Director · born 1969
- Mr. Hee-Soo YangVP & CFO · born 1968
- Mr. Dae-Won KimManaging Director · born 1968
- Mr. Seong-Bin ChoiManaging Director · born 1976
- Mr. Dong-Mok ShinVice President · born 1972